- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sodium-Glucose Transporter 2 Inhibitors
Total 16002 results
-
Duke UniversityRecruitingDiabetes Mellitus, Type 2 | Kidney Transplant; ComplicationsUnited States
-
University Hospital, Basel, SwitzerlandCentre Hospitalier Universitaire Vaudois; Luzerner KantonsspitalRecruitingLiver Failure | Hyponatremia | Kidney Failure | SIADHSwitzerland
-
Novo Nordisk A/SWithdrawnDiabetes Mellitus, Type 2Thailand, Malaysia, Poland, India, Hungary, Mexico, Brazil, United States, Croatia, Romania, Bulgaria, Greece, Serbia
-
Johns Hopkins UniversityUniversity of California, Los Angeles; AstraZeneca; Brett Boyer FoundationEnrolling by invitation
-
University Hospital Inselspital, BerneCompletedDumping Syndrome | Hypoglycemia, ReactiveSwitzerland
-
Caroline M KistorpRigshospitalet, Denmark; Herlev and Gentofte Hospital; Danish Heart FoundationCompletedType2 Diabetes MellitusDenmark
-
Holbaek SygehusEnrolling by invitationEnd Stage Renal Disease | Peritoneal Dialysis ComplicationDenmark
-
George Clinical Pty LtdUniversity Medical Center Groningen; Ground Zero PharmaceuticalsUnknownDiabetes Mellitus, Type 2 | Impaired Renal FunctionCanada
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited Kingdom
-
Dong-A ST Co., Ltd.CompletedHealthyKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Australia, Greece, Italy, Norway, Poland, Portugal, Sweden
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
AstraZenecaWithdrawn
-
Janssen-Cilag International NVCompleted
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy | Pharmacokinetics of ASP1941Taiwan
-
Hannover Medical SchoolBoehringer IngelheimNot yet recruitingAutosomal Dominant Polycystic Kidney
-
McGill University Health Centre/Research Institute...Heart and Stroke Foundation of CanadaNot yet recruitingESRD, CKD Stage 4, CKD Stage 5
-
Ottawa Heart Institute Research CorporationNot yet recruitingMyocardial Infarction | ST Elevation Myocardial InfarctionCanada
-
Chulalongkorn UniversityNot yet recruitingEmpagliflozin in Cardiorenal Syndrome Type 1Thailand
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...RecruitingHeart Failure | Kidney Diseases | Chronic Kidney Diseases | Heart Failure With Preserved Ejection FractionUnited States
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada
-
Albina Nowak, MDNot yet recruiting
-
Chinese University of Hong KongRecruitingAcute Heart FailureHong Kong
-
Chulalongkorn UniversityRecruitingEmpagliflozin in Post AKI Stage 2-3Thailand
-
Tor Biering-SørensenRecruitingChronic Kidney DiseasesDenmark
-
Boehringer IngelheimRecruitingHeart FailureKorea, Republic of
-
Kaohsiung Medical UniversityNot yet recruitingChronic Kidney Diseases
-
Jacob MollerRigshospitalet, Denmark; University Hospital Bispebjerg and Frederiksberg; Hillerod... and other collaboratorsRecruitingHeart Failure | ObesityDenmark
-
Center for Outcomes Research and Clinical Epidemiology...Italian Society of DiabetologyNot yet recruitingDiabetes Mellitus, Type 2
-
Assiut UniversityCompleted
-
University Medical Center GroningenAstraZenecaTerminated
-
Mario Negri Institute for Pharmacological ResearchAstraZenecaActive, not recruiting
-
Chang Gung Memorial HospitalActive, not recruitingCatheter Ablation | Atrial Fibrillation RecurrentTaiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Korea, Republic of, China, Germany, Belgium, Australia, Singapore, Canada, Italy, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, United Kingdom, Mexico, Romania, Brazil, India, South Africa, Colombia
-
Mutah UniversityCompletedPharmacokinetic ParametersJordan
-
University of GuadalajaraCompletedImpaired Glucose Tolerance | Prediabetes | Impaired Fasting GlucoseMexico
-
University of GuadalajaraCompletedMetabolic Syndrome XMexico
-
AstraZenecaCompleted
-
Morten SchouCompletedHeart Failure With Reduced Ejection FractionDenmark
-
Novartis PharmaceuticalsTerminatedDiabetes Mellitus and Heart FailureUnited States, Belgium, Austria, Croatia, Czechia, Netherlands, Canada, Korea, Republic of, Taiwan, Hungary, United Kingdom, Italy, Bulgaria, Germany, Argentina, Ireland, Norway, Spain, Denmark, Singapore, South Africa, Mexico, Poland, Puerto Rico
-
Medical University of ViennaCompletedPosttransplant Diabetes MellitusAustria
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Jichi Medical UniversityEli Lilly and Company; Boehringer IngelheimCompletedT2DM (Type 2 Diabetes Mellitus) | Nocturnal HypertensionJapan
-
University Health Network, TorontoAstraZeneca; University of Toronto; Toronto General HospitalCompletedFocal Segmental GlomerulosclerosisCanada
-
AstraZenecaMonash UniversityTerminated
-
Kinderkrankenhaus auf der BultCompleted
-
Astellas Pharma IncCompletedType 2 DiabetesJapan
-
Johnson & Johnson Pharmaceutical Research & Development...Completed